Top

Published in:

01-03-2004 | Original Article

CD34⁺ fibrocytes, α-smooth muscle antigen-positive myofibroblasts, and CD117 expression in the stroma of invasive squamous cell carcinomas of the oral cavity, pharynx, and larynx

Authors: Peter J. Barth, Titus Schenck zu Schweinsberg, Annette Ramaswamy, Roland Moll

Published in: Virchows Archiv | Issue 3/2004

Abstract

We investigated tumor-free mucosa and squamous cell carcinomas of the oral cavity, the pharynx, and larynx with respect to the presence of stromal CD34⁺ fibrocytes and α-smooth muscle antigen (SMA)-positive myofibroblasts. Additionally, stromal expression of CD117 was analyzed. A total of 39 squamous cell carcinomas were assessed immunohistochemically. In all cases investigated, CD34⁺ fibrocytes were found in the tumor-free stroma, whereas α-SMA-positive myofibroblasts were lacking. Areas of lymphocytic infiltration disclosed a focal reduction of CD34⁺ fibrocytes. CD117 expression was absent from the tumor-free stroma. Of 39 squamous cell carcinomas, 33 were free of stromal CD34⁺ fibrocytes, and, in 31 carcinomas, stromal α-SMA-positive myofibroblasts occurred at least focally. CD117-positive stromal spindle cells were found in 25 carcinomas. Compared with tumor-free mucosa, the number of tissue mast cells was significantly increased in carcinomas. We conclude that stromal remodeling induced by invasive carcinomas is characterized by a loss of CD34⁺ fibrocytes and subsequent gain of α-SMA-positive myofibroblasts. The diagnostic impact of this finding is, however, limited by the fact that chronic inflammation may also be accompanied by a focal loss of CD34⁺ fibrocytes.

Abe R, Donnelly SC, Peng T, Bucala R, Metz CN (2001) Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J Immunol 166:7556–7562PubMed

Barth PJ, Ebrahimsade S, Hellinger A, Moll R, Ramaswamy A (2002) CD34⁺ fibrocytes in neoplastic and inflammatory pancreatic lesions. Virchows Arch 440:128–133PubMed

Barth PJ, Ebrahimsade S, Ramaswamy A, Moll R (2002) CD34⁺ fibrocytes in invasive ductal carcinoma, ductal carcinoma in situ, and benign breast lesions. Virchows Arch 440:298–303PubMed

Barth PJ, Ramaswamy A, Moll R (2002) CD34⁺ fibrocytes in normal cervical stroma, cervical intraepithelial neoplasia III, and invasive squamous cell carcinoma of the cervix uteri. Virchows Arch 441:564–568CrossRefPubMed

Bucala R, Spiegel LA, Chesney J, Hogan M, Cerami A (1994) Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med 1:71–81PubMed

Chauhan H, Abraham A, Phillips JR, Pringle JH, Walker RA, Jones JL (2003) There is more than one kind of myofibroblast: analysis of CD34 expression in benign, in situ, and invasive breast lesions. J Clin Pathol 56:271–276CrossRefPubMed

Chesney J, Bacher M, Bender A, Bucala R (1997) The peripheral blood fibrocyte is a potent antigen-presenting cell capable of priming naive T cells in situ. Proc Natl Acad Sci U S A 94:6307–6312PubMed

Chesney J, Metz C, Stavitsky AB, Bacher M, Bucala R (1998) Regulated production of type I collagen and inflammatory cytokines by peripheral blood fibrocytes. J Immunol 160:419–425PubMed

Hagedorn H, Elbertzhagen A, Ruoss I, Sauer U, Nerlich AG (2001) Immunohistochemical analysis of major TGF-beta isoforms and their receptors in laryngeal carcinomas. Virchows Arch 439:531–539PubMed

10.

Hartlapp I, Abe R, Saeed RW, Peng T, Voelter W, Bucala R, Metz CN (2001) Fibrocytes induce an angiogenic phenotype in cultured endothelial cells and promote angiogenesis in vivo. FASEB J 15:2215–2224CrossRefPubMed

11.

Humphreys TR, Monteiro MR, Murphy GF (2000) Mast cells and dendritic cells in basal cell carcinoma stroma. Dermatol Surg 26:200–203CrossRefPubMed

12.

Kirchmann TT, Prieto VG, Smoller BR (1994) CD34 staining pattern distinguishes basal cell carcinoma from trichoepithelioma. Arch Dermatol 130:589–592PubMed

13.

Koliopanos A, Friess H, di Mola FF, Tang WH, Kubulus D, Brigstock D, Zimmermann A, Buchler MW (2002) Connective tissue growth factor gene expression alters tumor progression in esophageal cancer. World J Surg 26:420–427CrossRefPubMed

14.

Nakayama H, Enzan H, Miyazaki E, Kuroda N, Naruse K, Hiroi M (2000) Differential expression of CD34 in normal colorectal tissue, peritumoral inflammatory tissue, and tumour stroma. J Clin Pathol 53:626–629

15.

Nakayama H, Enzan H, Miyazaki E, Kuroda N, Naruse K, Kiyoku H, Toi M, Hiroi M (2001) CD34 positive stromal cells in gastric adenocarcinomas. J Clin Pathol 54:846–848

16.

Natsugoe S, Xiangming C, Matsumoto M, Okumura H, Nakashima S, Sakita H, Ishigami S, Baba M, Takao S, Aikou T (2002) Smad4 and transforming growth factor beta1 expression in patients with squamous cell carcinoma of the esophagus. Clin Cancer Res 8:1838–1842PubMed

17.

Ramaswamy A, Moll R, Barth PJ (2003) CD34⁺ fibrocytes in tubular carcinomas and radial scars of the breast. Virchows Arch 443:536–540CrossRefPubMed

18.

Soma L, LiVolsi VA, Baloch ZW (2001) Dendritic interstitial and myofibroblastic cells at the border of salivary gland tumors. Arch Pathol Lab Med 125:232–236PubMed

19.

Welker P, Grabbe J, Zuberbier T, Grutzkau A, Henz BM (2001) GM-CSF downmodulates c-kit, FcεRIα and GM-CSF receptor expression as well as histamine and tryptase levels in cultured human mast cells. Arch Dermatol Res 293:249–258PubMed

20.

Zidar N, Gale N, Kambic V, Fischinger J (2002) Proliferation of myofibroblasts in the stroma of epithelial hyperplastic lesions and squamous carcinoma of the larynx. Oncology 62:381–385CrossRefPubMed

Title: CD34+ fibrocytes, α-smooth muscle antigen-positive myofibroblasts, and CD117 expression in the stroma of invasive squamous cell carcinomas of the oral cavity, pharynx, and larynx
Authors: Peter J. Barth
Titus Schenck zu Schweinsberg
Annette Ramaswamy
Roland Moll
Publication date: 01-03-2004
Publisher: Springer-Verlag
Published in: Virchows Archiv / Issue 3/2004
Print ISSN: 0945-6317
Electronic ISSN: 1432-2307
DOI: https://doi.org/10.1007/s00428-003-0965-1

Keynote webinar | Spotlight on medication adherence

Springer Medicine

CD34⁺ fibrocytes, α-smooth muscle antigen-positive myofibroblasts, and CD117 expression in the stroma of invasive squamous cell carcinomas of the oral cavity, pharynx, and larynx

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2004

Metachronous and multiple aneurysmal bone cysts: a rare variant of primary aneurysmal bone cysts

Endocardial location of familial myofibromatosis revealed by cerebral embolization: cardiac counterpart of the frequent intravascular growth of the disease?

March 2004

Rare KIT (CD117) expression in multiple myeloma abrogates the usefulness of imatinib mesylate treatment

Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification

Immunohistochemical characterization of fibroblast subpopulations in normal peritoneal tissue and in peritoneal dialysis-induced fibrosis